Adjuvant chemotherapy with cisplatin, ifosfamide, and doxorubicin followed by radiotherapy in localized uterine sarcomas: results of a case-control study with radiotherapy alone
- 30 November 2004
- journal article
- clinical trial
- Published by Elsevier in International Journal of Gynecologic Cancer
- Vol. 14 (6) , 1112-1117
- https://doi.org/10.1111/j.1048-891x.2004.14609.x
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Cisplatin-based chemotherapy regimen (DECAV) for uterine sarcomasInternational Journal of Gynecologic Cancer, 2002
- Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcomaCancer, 2000
- Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual dataThe Lancet, 1997
- Phase II trial of ifosfamide and mesna in leiomyosarcoma ofthe uterus: A Gynecologic Oncology Group studyAmerican Journal of Obstetrics and Gynecology, 1992
- Phase II trial of ifosfamide and mesna in mixed mesodermal tumors of the uterus (A Gynecologic Oncology Group Study)American Journal of Obstetrics and Gynecology, 1989
- High-dose doxorubicin infusion therapy for disseminated mixed mesodermal sarcoma of the uterusCancer, 1987
- Adjuvant therapy for Stage I uterine sarcomaAmerican Journal of Obstetrics and Gynecology, 1987
- A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: a Gynecologic Oncology Group Study.Journal of Clinical Oncology, 1985
- A randomized study of adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced uterine sarcomasCancer, 1983
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958